New ESMO recommendations on the use of ctDNA
Developed by the ESMO Precision Medicine Working Group, they provide guidance to medical oncologists on the use of circulating tumour DNA assays in clinical practice
News
Polygenic scores for cancer prevention: a new IARC webinar
The role of polygenic scores for stratified cancer prevention, and the genetic determinants for PSA levels to improve cancer screening utility will be debated during the sixth instalment in the World Cancer Report Updates webinar series.
ESMO supports World Cancer Day 2022
This year, World Cancer Day is launching #CloseTheCareGap, a three-year campaign aiming to promote awareness, collaboration, and action for a more equitable future in cancer care.
ESMO releases twenty-three new statements on COVID-19 vaccination in people with cancer
Based on current knowledge available, they address key questions on safety and efficacy of COVID-19 vaccines, their interference with anticancer treatment, and advocate for a global strategy for the booster dose
ESMO partners with the Lancet Commission on Women and Cancer to advancing gender equity in cancer
ESMO President will act as an Advisor
A new IARC live webinar on evidence in primary cancer prevention
Experts discuss a wealth of challenges and opportunities in primary cancer prevention that oncologists themselves must take on
Female representation at the top of the oncology field has hit a plateau
With modest progress being made in the gender balance of the oncology field in recent years, women continue to be underrepresented in leadership positions despite making up an increasing proportion of the oncology workforce.
ESMO endorses joint editorial from health journals on climate crisis
Over 200 leading health journals, including Annals of Oncology, published a joint editorial urging governments to take actions to limit global temperature increases, restore biodiversity, and protect health.
COVID-19 pandemic takes a toll on women’s career in oncology
An ESMO Women for Oncology survey warns the health crisis is widening the gender gap as data shows that female oncologists have managed to dedicate less time to science during and after lockdowns
Obesity and cancer, a new webinar from the ESMO-IARC partnership
ESMO continues its commitment to improve cancer prevention worldwide through the collaboration with IARC
Reinforcing local actions in Asia during the pandemic era
ESMO’s commitment in the region continues with a new plan for Pan-Asian adaptations of the ESMO Clinical Practice Guidelines
25 Years of EMA and its long lasting partnership with ESMO
ESMO joined an EMA virtual meeting marking 25 years of its strong commitment to protect public health with a focus on cancer. Lectures from ESMO’s spokespersons were streamed.
Toward sustainable cancer care: the value of ESMO’s tools receives global recognition
Two years ago, the World Health Organisation (WHO) invited the Society to assist in the evaluation of Kazakhstan’s cancer treatment protocols and medicines, which has led today to the improvement of cancer care services in the Asian country.
Featured content
HER2+ breast cancer: from no hope to good prognosis in 20 years
Trastuzumab has transformed the prognosis for women with HER2+ breast cancer. On the occasion of the ESMO Breast Cancer Virtual Congress 2021, leading oncology experts recall with enthusiasm the pioneering work of researchers like José Baselga in this field and push for continuous research to investigate how to further improve the treatment of this cancer sub-type
Should we invest more in registry data?
During the COVID-19 pandemic, real-world data have shown they can support clinical decision-making in complex situations but extensive bureaucracy is still a limiting factor
Cancer vaccination: a new era of innovation
Promising results with cancer vaccines based on specific antigen mutations in individual tumours, and typically used in combination with checkpoint inhibitors, are fuelling an upsurge of interest in cancer vaccination for patients with established cancer, explains Prof. Pedro Romero.